|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-11-20
|
|
pubmed:abstractText |
Toxicity and quality of life issues have moved to delay the initiation of highly active antiretroviral therapy (HAART) and to explore novel treatment strategies for HIV infection. The switch to simpler regimens or treatment discontinuation has been attempted with limited success. The combination of hydroxyurea (HU) plus didanosine (ddI) is a simple regimen that might be able to restrain virus replication for long periods of time and could be an acceptable option as maintenance therapy in patients on prolonged successful HAART.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
361-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14628279-Adult,
pubmed-meshheading:14628279-Anti-HIV Agents,
pubmed-meshheading:14628279-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:14628279-CD4 Lymphocyte Count,
pubmed-meshheading:14628279-Didanosine,
pubmed-meshheading:14628279-Drug Administration Schedule,
pubmed-meshheading:14628279-Drug Therapy, Combination,
pubmed-meshheading:14628279-Female,
pubmed-meshheading:14628279-HIV Infections,
pubmed-meshheading:14628279-Humans,
pubmed-meshheading:14628279-Hydroxyurea,
pubmed-meshheading:14628279-Male,
pubmed-meshheading:14628279-Nucleic Acid Synthesis Inhibitors,
pubmed-meshheading:14628279-Survivors,
pubmed-meshheading:14628279-Treatment Outcome,
pubmed-meshheading:14628279-Viral Load
|
|
pubmed:articleTitle |
Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy.
|
|
pubmed:affiliation |
Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
